Subscription for Prostate Cancer Newsletter | Us Too International

Us TOO distributes a series of emails along with NEWS You Can Use twice a month. It’s a FREE news feed with some of the latest information that’s of interest to the prostate cancer community.

Subscribe to the news feed and emails from Us TOO.

 
 

Us TOO Prostate Cancer NEWS You Can Use

European Commission approves Astellas' prostate cancer drug enzalutamide

The European Commission (EC) has granted a variation to amend the marketing authorization for Astellas Pharma's enzalutamide (XTANDI) to treat men with metastatic castration-

XTANDI™ (enzalutamide) Now Approved in Europe for the Treatment of Men with Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve

Enzalutamide significantly reduced the risk of radiographic progression or death by 81% compared with placebo Enzalutamide demonstrated a significant impact on overall survival

SOTIO Initiates US part of VIABLE, a Global Phase III Clinical Trial for Prostate Cancer Immunotherapy Treatment with DCVAC/PCa

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- SOTIO, a biotechnology company owned by the PPF Group, announced that the first US patient has been enrolled in its

Innocrin Pharmaceuticals and the Prostate Cancer Foundation Join Forces for Phase 2 Clinical Study

Innocrin Pharmaceuticals highlighted its participation in a multi- center Phase 2 clinical study of VT-464 in prostate cancer patients resistant to next-generation androgen

New Data from a Pooled Analysis Shows Improved Overall Survival for Prostate Cancer Patients Treated With FIRMAGON® Degarelix Compared To LHRH...

New Data from a Pooled Analysis Shows Improved Overall Survival for Prostate Cancer Patients Treated With FIRMAGON® Degarelix Compared To LHRH Agonists By a News Reporter-Staff

ArQule Announces Positive Top-Line Results of NIH-Sponsored Phase 2 Trial of Tivantinib in Prostate Cancer

By a News Reporter-Staff News Editor at Biotech Week -- ArQule, Inc. (NASDAQ: ARQL) announced positive top-line results from a randomized, double-blind, placebo-controlled Phase 2

Studies from University of Dusseldorf Yield New Data on Prostate Cancer (Prospective Evaluation of Magnetic Resonance Imaging Guided In-bore Prostate...

Studies from University of Dusseldorf Yield New Data on Prostate Cancer (Prospective Evaluation of Magnetic Resonance Imaging Guided In-bore Prostate Biopsy versus Systematic

Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for...

Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy

Exelixis Announces Results from the COMET-2 Pivotal Phase 3 Trial of Cabozantinib in Men With Metastatic Castration-Resistant Prostate Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-2, a randomized, double-blind

Molecular breakthrough could halt the spread of prostate cancer

By a News Reporter-Staff News Editor at Biotech Week -- Scientists believe a new treatment, shown to be effective in mice, could halt the growth of tumours in patients with

Blood vessel protein could help treat prostate tumours: Study

A signal protein, that plays a crucial role in controlling the growth of blood vessels, could be used to suppress tumours in prostate cancer, according to a new study published in

Nutrient and Botanical Supplement ProstaCaid Shows Promise for Prostate Health and Related Conditions

By a News Reporter-Staff News Editor at Cancer Weekly -- A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid

New Prostate Cancer Study Findings Reported from Duke University (Copper Signaling Axis as a Target for Prostate Cancer Therapeutics)

By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on Oncology have been presented. According to news reporting out of Durham, North Carolina, by NewsRx

Galeterone shows activity in a variant form of castration-resistant prostate cancer

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Barcelona, Spain: Results from a trial of the anti-cancer drug galeterone show that it is successful in lowering

Conventional therapies are less efficient in prostate cancer patients carrying 'BRCA' mutations

By a News Reporter-Staff News Editor at Biotech Week -- The study has been led by David Olmos and Elena Castro at the Spanish National Cancer Research Centre (CNIO) and Rosalind

Findings from Duke University in the Area of Prostate Cancer Reported (Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the...

Findings from Duke University in the Area of Prostate Cancer Reported (Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the REDUCE Study) By a News Reporter-

New Health and Medicine Study Results Reported from University of Southampton (Depression and anxiety in prostate cancer: a systematic review and...

New Health and Medicine Study Results Reported from University of Southampton (Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates

New Prostate Cancer Findings Has Been Reported by Investigators at Virginia Commonwealth University (AEG-1 Promoter-Mediated Imaging of Prostate...

New Prostate Cancer Findings Has Been Reported by Investigators at Virginia Commonwealth University (AEG-1 Promoter-Mediated Imaging of Prostate Cancer) By a News Reporter-Staff

American Institute for Cancer Research Report Shows Obesity Now Linked to Deadliest Prostate Cancers

A report from an ongoing systematic review of global research finds that being overweight or obese increases men's risk for the deadliest forms of prostate cancer. According to a

NCI -Thomas Jefferson U researchers find that HIV drug blocks bone metastases in prostate cancer

ENP Newswire - 02 December 2014 Release date- 01122014 - (PHILADELPHIA) - Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the

Leading International Scientists Announce New Guidelines for Improved Prostate Cancer Diagnosis

RESTON, Va., Dec. 1 -- The American College of Radiology issued the following news release: The Joint Steering Committee of the American College of Radiology (ACR), AdMeTech

Garlic, broccoli may speed up cancer recovery

Researchers from the University of Copenhagen have found that selenium naturally found in garlic and broccoli slows down immune overresponse, improving treatment against cancers

'Tis the season to indulge in walnuts

By a News Reporter-Staff News Editor at Cancer Weekly -- (SACRAMENTO, Calif.) - Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut

Dendreon files for Ch. 11 bankruptcy protection

Prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection with a plan that leads to either a sale of the company or a takeover by its lenders. The Seattle

Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy

SAN FRANCISCO, CA and NORTHBROOK, IL -- (Marketwired) -- 10/30/14 -- Medivation Inc. (NASDAQ: MDVN) and Astellas today announced plans to initiate a global Phase 3 clinical trial

Study Results from Janssen Research and Development Provide New Insights into Prostate Cancer (Response to Subsequent Docetaxel in a Patient Cohort...

Study Results from Janssen Research and Development Provide New Insights into Prostate Cancer (Response to Subsequent Docetaxel in a Patient Cohort With Metastatic Castration-

Metamark Announces Nationwide Availability of ProMark™ Prostate Cancer Test, First-of-its-Kind Protein-Based Prognostic Test

By a News Reporter-Staff News Editor at Cancer Weekly -- Metamark announced the nationwide availability of ProMark™, the first-of-its-kind protein-based biopsy test designed to

ValiRx VAL201 Phase I/II Trial Ready To Begin Recruitment

LONDON (Alliance News) - ValiRx PLC said Tuesday that it can begin the recruitment of patients in its phase I/II trial of developmental prostate cancer treatment VAL201, following

OPKO Health Supports National Prostate Cancer Council Legislation

By a News Reporter-Staff News Editor at Cancer Weekly -- OPKO Health, Inc. (NYSE: OPK) is pleased to lend its support to the legislation introduced in the United States Senate on

Researchers discover gene that can predict aggressive prostate cancer at diagnosis

By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3

RNA molecules in urine can detect prostate cancer

Washington, Oct 11 (ANI): Scientists have revealed that they have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but

Prostate cancer, kidney disease detected in urine samples on the spot

By a News Reporter-Staff News Editor at Cancer Weekly -- When you flush the toilet, you may be discarding microscopic warning signs about your health (see also Kidney Disease). But

Patent Issued for Methods for Detecting Risk of Fatal Prostate Cancer Using Serum Calcium

By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors

UT Arlington research uses artificial lymph nodes to attract prostate cancer cells

Cancer decoys A UT Arlington bioengineering professor is using tissue-engineered artificial lymph nodes to attract prostate cancer cells to better target and eradicate the disease

High cholesterol ups risk of prostate cancer recurrence

Higher levels of cholesterol and triglycerides, two types of fat, in the blood of men who underwent surgery for prostate cancer, may increase risk of disease recurrence, says a

Missing link between vitamin D & prostate cancer

A University of Colorado Cancer Center study recently published in the journal Prostate offers compelling evidence that inflammation may be the link between vitamin D and prostate

Reports Outline Prostate Cancer Study Results from University of Calgary [A population study of fasting time and serum prostate-specific antigen...

Reports Outline Prostate Cancer Study Results from University of Calgary [A population study of fasting time and serum prostate-specific antigen (PSA) level] By a News Reporter-

Study Data from University of Colorado Update Knowledge of Prostate Cancer (Targeted Focal Therapy for the Management of Organ Confined Prostate...

Study Data from University of Colorado Update Knowledge of Prostate Cancer (Targeted Focal Therapy for the Management of Organ Confined Prostate Cancer) By a News Reporter-Staff

Findings from Memorial Sloan-Kettering Cancer Center in the Area of Prostate Cancer Reported (Relative Value of Race, Family History and Prostate...

Findings from Memorial Sloan-Kettering Cancer Center in the Area of Prostate Cancer Reported (Relative Value of Race, Family History and Prostate Specific Antigen as Indications

Studies from City Hospital Have Provided New Data on Prostate Cancer (Bilaterally Positive Biopsy Cores Are Associated with Non-Organ-Confined...

Studies from City Hospital Have Provided New Data on Prostate Cancer (Bilaterally Positive Biopsy Cores Are Associated with Non-Organ-Confined Disease in Prostate Cancer Patients

New Findings from University of Minnesota Update Understanding of Prostate Cancer (Selectively Targeting the DNA-binding Domain of the Androgen...

New Findings from University of Minnesota Update Understanding of Prostate Cancer (Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy

Reports from Cleveland Clinic Advance Knowledge in Prostate Cancer (Is There a Role for Body Mass Index in the Assessment of Prostate Cancer Risk on...

Reports from Cleveland Clinic Advance Knowledge in Prostate Cancer (Is There a Role for Body Mass Index in the Assessment of Prostate Cancer Risk on Biopsy?) By a News Reporter-

Reports Summarize Prostate Cancer Findings from University of Sydney (The struggle towards 'the New Normal': a qualitative insight into psychosexual...

Reports Summarize Prostate Cancer Findings from University of Sydney (The struggle towards 'the New Normal': a qualitative insight into psychosexual adjustment to prostate cancer

New Prostate Cancer Findings from University of Eastern Finland Described (Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle...

New Prostate Cancer Findings from University of Eastern Finland Described (Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study) By a News Reporter-Staff

Prostate cancer medications linked with increased risk of heart-related deaths in men with cardiovascular problems

By a News Reporter-Staff News Editor at Heart Disease Weekly -- A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart

Researchers from Oregon State University Report on Findings in Prostate Cancer (Transcriptome analysis reveals a dynamic and differential...

Researchers from Oregon State University Report on Findings in Prostate Cancer (Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane

New Prostate Cancer Study Findings Have Been Reported by Investigators at Keio University (Individualized Prostate-specific Antigen Threshold Values...

New Prostate Cancer Study Findings Have Been Reported by Investigators at Keio University (Individualized Prostate-specific Antigen Threshold Values to Avoid Overdiagnosis of

New Findings in Prostate Cancer Described from Central Hospital (Overexpression of oxidored-nitro domain containing protein 1 induces growth...

New Findings in Prostate Cancer Described from Central Hospital (Overexpression of oxidored-nitro domain containing protein 1 induces growth inhibition and apoptosis in human

Study Results from McGill University in the Area of Prostate Cancer Reported (Post-diagnostic use of beta-blockers and the risk of death in patients...

Study Results from McGill University in the Area of Prostate Cancer Reported (Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer) By a News

ASCO Endorses Guide on Adjuvant RT in Prostate Cancer

The American Society of Clinical Oncology (ASCO) has endorsed guidelines from the American Urological Association (AUA)/American Society for Radiation Oncology (ASTRO) on the use

Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer

By a News Reporter-Staff News Editor at Clinical Trials Week -- Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll

New non-invasive technique could revolutionize the imaging of metastatic cancer

By a News Reporter-Staff News Editor at Clinical Trials Week -- Bioluminescence, nanoparticles, gene manipulation - these sound like the ideas of a science fiction writer, but, in

Blood test could identify when cancer treatment has become detrimental

By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Some treatments for prostate cancer, while initially effective at controlling the disease, not only stop

Pitt study uncovers prostate cancer mystery

Sept. 16--No method currently exists to gauge the aggressiveness of prostate cancer, putting the patient and his doctors into a quandary about the proper treatment strategy. Should

Findings from University of Michigan Provides New Data on Prostate Cancer (Risk of Second Primary Tumors in Men Diagnosed With Prostate Cancer) (Risk...

Findings from University of Michigan Provides New Data on Prostate Cancer (Risk of Second Primary Tumors in Men Diagnosed With Prostate Cancer) (Risk of Second Primary Tumors in

OncoGenex Announces Completion of Patient Enrollment in the Phase 3 AFFINITY Trial of Custirsen in Combination with Cabazitaxel/Prednisone as...

OncoGenex Announces Completion of Patient Enrollment in the Phase 3 AFFINITY Trial of Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Men with

Genetic testing can identify men at 6-fold increased risk of prostate cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified

Prostate Cancer Awareness Month - Stop Random Biopsies

By a News Reporter-Staff News Editor at Cancer Weekly -- Prostate Oncology Specialists announces the launch of the Prostate Vanguard, an awareness campaign to educate men about new

Findings in Urology Reported from Veterans Affairs Medical Center (Multiple Repeat Prostate Biopsies and the Detection of Clinically Insignificant...

Findings in Urology Reported from Veterans Affairs Medical Center (Multiple Repeat Prostate Biopsies and the Detection of Clinically Insignificant Cancer in Men With Large

Investigators at Harvard School of Public Health Report New Data on Cancer Research (Gleason grade progression is uncommon)

By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology have been published. According to news originating from Boston, Massachusetts, by NewsRx

NCI -MD Anderson researchers discover gene that might predict aggressive prostate cancer at diagnosis

ENP Newswire - 06 October 2014 Release date- 03102014 - Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3

Studies from Ohio State University Yield New Information about Clinical Trials and Studies [The Individualized Diet and Exercise Adherence Pilot...

Studies from Ohio State University Yield New Information about Clinical Trials and Studies [The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer

Metamark Announces Portfolio Expansion To Include PROGENSA® PCA3 And ERG Tests For Assessing Prostate Cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- Metamark announced the expansion of its prostate cancer test services to now include the PROGENSA(®) PCA3 assay, a urine-

Patent Issued for Male Urethral Prosthesis with Tensioning Member

By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Siegel, Steven W. (North Oaks, MN); Arnal, Kevin R. (Chanhassen, MN); Lund, Robert E. (St. Michael